Released Aug 9, 2012, after the close
10-Q filed Aug 9, 2012, 40 days after period end · 0001144204-12-044116
Q2 2012 · 10-Q
Revenue—
Net Income-$7.47M-$7.47M N/M vs Q2 2011N/M vs Q1 2012
EPS Diluted-$0.59-$0.59 N/M vs Q2 2011N/M vs Q1 2012
Operating Income-$7,478,306N/M
Operating Cash Flowderived-$6,935,579N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Net Income | -$7.47M | -$6.96M | -$2.13M |
| EPS Diluted | -$0.59 | -$0.97 | -$4.76 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR